Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00732082
Recruitment Status : Terminated (Company manufacturing study drug was unable to continue production.)
First Posted : August 11, 2008
Last Update Posted : June 12, 2013
Sponsor:
Information provided by (Responsible Party):
Washington University School of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : February 2010
Actual Study Completion Date : September 2012
Publications:
Immutep. 2006. ImmuFact IMP321 Product Information Brochure.
Co, E.L.a., Gemcitabine Product Info. 2003.
Series, M.H., 2003. MICROMEDEX, Greenwood Village, Colorado